|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 24, 2002
Am J Physiol Regu Physiol, 10.1152/ajpregu.00570.2002
Submitted on September 16, 2002
Accepted on October 22, 2002
1 Trauma Research, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA
2 Barrow Neurological Institute, Neurology Research, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA
* To whom correspondence should be addressed. E-mail: aromano{at}chw.edu.
Prostaglandin (PG) E2 is a principal downstream mediator of fever and other symptoms of systemic inflammation. Its inactivation occurs in peripheral tissues, primarily the lungs and liver, via carrier-mediated cellular uptake and enzymatic oxidation. We hypothesized that inactivation of PGE2 is suppressed during lipopolysaccharide (LPS) fever, and that transcriptional down-regulation of PGE2 carriers and catabolizing enzymes contributes to this suppression. Fever was induced in inbred Wistar Kyoto rats by intravenous LPS (50 µg/kg); the controls received saline. Samples of the liver, lungs, and hypothalamus were harvested 0, 0.5, 1.5, and 5 h postinjection. The expression of the two principal transmembrane PGE2 carriers (PG transporter and multispecific organic anion transporter) and the two key PGE2-inactivating enzymes [15-hydroxy-PG dehydrogenase (15-PGDH) and carbonyl reductase] was quantified by RT-PCR. All four genes of interest were down-regulated in peripheral tissues (but not the brain) during fever. Most remarkably, the expression of hepatic 15-PGDH was decreased 26 fold 5 h post-LPS, whereas expression of pulmonary 15-PGDH was down-regulated (as much as 18 fold) throughout the entire febrile course. The transcriptional down-regulation of several proteins involved in PGE2 inactivation, first reported here, is an unrecognized mechanism of systemic inflammation. By increasing the blood-brain gradient of PGE2, this mechanism likely facilitates penetration of PGE2 into the brain and prevents its elimination from the brain.
This article has been cited by other articles:
![]() |
Y. Ootsuka, W. W. Blessing, A. A. Steiner, and A. A. Romanovsky Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1294 - R1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Ivanov, A. A. Steiner, A. C. Scheck, and A. A. Romanovsky Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats Physiol Genomics, April 14, 2005; 21(2): 152 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. C. Fabricio, F. H. Veiga, R. Cristofoletti, P. Navarra, and G. E. P. Souza The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R671 - R677. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Romanovsky Anorexia: the toll for lipopolysaccharide recognition Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R274 - R275. [Full Text] [PDF] |
||||
![]() |
A. A. Romanovsky and S. R. Petersen The spleen: another mystery about its function Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1378 - R1379. [Full Text] [PDF] |
||||
![]() |
A. I. Ivanov, A. A. Romanovsky, K. Matsumura, A. Mouihate, M. S. Clerget-Froidevaux, J. L. Wallace, and Q. J. Pittman Near-term suppression of fever: inhibited synthesis or accelerated catabolism of prostaglandin E2? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R860 - R865. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |